Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation

Completed · Phase 1/Phase 2

Conditions studied: Aging

In brief

Autologous platelet rich fibrin matrix will release growth factors which could increase the production of dermal proteins or affect the vascularity and status of neighboring tissues. This study is designed to evaluate the histologic and biochemical effect of injection of platelet rich fibrin matrix into the skin.

Key facts

Study ID

NCT00956020

Run by

The New York Eye & Ear Infirmary

People needed

4

Starts

2009-10-01

Expected to finish

2011-07-01

Last updated by the study team

2015-12-16

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 25 and 75 years of age

You may not qualify if…

• collagen vascular disorders
• autoimmune diseases
• signs or history of impaired wound healing
• shall not have had any infectious or inflammatory processes at the treatment sites within the prior 6 months

Where it is running

• The NY Eye & Ear Infirmary — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.